An investigation for investors in Henry Schein, Inc. (NASDAQ:HSIC) shares over potential securities laws violations by Henry Schein, Inc. was announced and NASDAQ:HSIC stockholders should contact the Shareholders Foundation.
San Diego, CA -- (SBWIRE) -- 02/26/2018 -- An investigation was announced for investors of Henry Schein, Inc. concerning potential securities laws violations by Henry Schein, Inc in connection with certain financial statements.
Investors who purchased shares of Henry Schein, Inc. (NASDAQ:HSIC), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Henry Schein, Inc. (NASDAQ:HSIC) concerning whether a series of statements by Henry Schein, Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
Melville, NY based Henry Schein, Inc. is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. Henry Schein, Inc. Reported that ist Total Revenue rose from over $10.62 billion in 2015 to over $11.57 billion in2016 and its Net Income increased from $479.06 million in 2015 to $506.78 million in 2016.
On February 12, 2018, it was reported that the Federal Trade Commission (FTC) has filed a complaint against the three largest U.S. dental supply companies in the country, including Henry Schein, Inc. The complaint alleges that the companies conspired to prevent dental groups from buying their products in bulk at a discount.
Those who purchased shares of Henry Schein, Inc. (NASDAQ:HSIC) have certain options and should contact the Shareholders Foundation.
Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com